Peptide Comparison
Human Chorionic Gonadotropin (HCG)vsLeuprolide
A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.
A powerful GnRH agonist that helps manage hormone-sensitive conditions by controlling hormone production.
At a Glance
Quick
comparison
Dose Range
Human Chorionic Gonadotropin (HCG)
250–2000 IU
Leuprolide
3.75 mg–45 mg monthly or 3-month injections (depending on formulation)
Frequency
Human Chorionic Gonadotropin (HCG)
Twice weekly
Leuprolide
Once daily
Administration
Human Chorionic Gonadotropin (HCG)
Subcutaneous injection
Leuprolide
Subcutaneous injection (daily)
Cycle Length
Human Chorionic Gonadotropin (HCG)
Ongoing/indefinite
Leuprolide
Ongoing/indefinite
Onset Speed
Human Chorionic Gonadotropin (HCG)
Moderate (1-2 weeks)
Leuprolide
Moderate (1-2 weeks)
Evidence Level
Human Chorionic Gonadotropin (HCG)
Strong human trials (Phase 3 or FDA approved)
Leuprolide
Strong human trials (Phase 3 or FDA approved)
Efficacy
Benefit
ratings
Fertility Preservation
Testicular Health
Hormone Balance
Cancer Management
Endometriosis & Fibroid Relief
Hormone Control
Technical Data
Compound
specifications
Human Chorionic Gonadotropin (HCG)
Molecular Formula
C1105H1770N318O336S26 (approximate)
Molecular Weight
36,700 g/mol (approximately)
Half-Life
24-36 hours
Bioavailability
High when injected subcutaneously or intramuscularly
CAS Number
9002-61-3
Leuprolide
Molecular Formula
C59H84N16O12
Molecular Weight
1209.4 g/mol
Half-Life
Approximately 2-6 hours (varies by route of administration)
Bioavailability
~95% (subcutaneous injection)
CAS Number
74381-53-6
Protocols
Dosing
tiers
Human Chorionic Gonadotropin (HCG)
Leuprolide
Applications
Best
suited for
Human Chorionic Gonadotropin (HCG)
Fertility Preservation During TRT
If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men.
Preventing Testicular Atrophy
Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function.
Hypogonadotropic Hypogonadism
If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility.
Post-Cycle Therapy (PCT)
After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol.
Leuprolide
Managing advanced or metastatic prostate cancer
Leuprolide is particularly well-suited for individuals focused on managing advanced or metastatic prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Controlling severe endometriosis pain
Leuprolide is particularly well-suited for individuals focused on controlling severe endometriosis pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Treating symptomatic uterine fibroids
Leuprolide is particularly well-suited for individuals focused on treating symptomatic uterine fibroids. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Delaying early puberty in children
Leuprolide is particularly well-suited for individuals focused on delaying early puberty in children. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety Profile
Side
effects
Human Chorionic Gonadotropin (HCG)
Common
- Injection site reactions
- Headache
- Water retention
Uncommon
- Gynecomastia
- Mood changes
- Acne
Serious
- Blood clots
Leuprolide
Common
- Hot flashes (very common in men)
- Decreased libido and erectile dysfunction
- Injection site pain or swelling
- Nausea
- Fatigue
- Mood changes or depression
- Joint or muscle pain
- Headaches
- Dizziness
- Thinning hair
- Decreased bone density (osteoporosis with long-term use)
- QT prolongation (rare but serious cardiac effect)
- Tumor flare (temporary worsening of cancer symptoms in first weeks)
- Severe allergic reactions
- Spinal cord compression risk in men with metastatic disease
Serious
- Severe allergic reaction
Research Status
Safety
& evidence
Human Chorionic Gonadotropin (HCG)
Evidence Level
Strong human trials (Phase 3 or FDA approved)
FDA Status
FDA approved for other use
Safety Overview
HCG has been used medically for over 80 years with a well-established safety profile. When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. Serious side effects are rare when HCG is used under medical supervision.
Contraindications
- xHormone-sensitive cancers (prostate, breast)
- xPrecocious puberty in children
- xKnown allergy to HCG or any component
- xPregnancy (in therapeutic male contexts)
- xUntreated thyroid or adrenal disorders
Leuprolide
Evidence Level
Strong human trials (Phase 3 or FDA approved)
FDA Status
FDA approved for this use
Safety Overview
Leuprolide (Lupron) is an FDA-approved GnRH agonist with 35+ years of clinical safety data involving millions of patients in oncology and endocrinology. The critical safety issue is the initial 5-7 day flare effect—temporary surge in FSH/LH causing symptom worsening before hormone suppression begins—particularly dangerous for prostate cancer patients (flare can cause urinary obstruction or spinal cord compression). Bone density loss is a dose-dependent long-term risk in both men and women requiring monitoring. Injection site reactions, hot flushes, and initial hypogonadal symptoms are expected and typically transient.
Contraindications
- xPregnancy or breastfeeding (teratogenic)
- xUndiagnosed vaginal bleeding
- xActive bone metastases with spinal cord compression (increased fracture risk)
- xAllergy to GnRH agonists or components
- xSevere cardiovascular disease with QT prolongation risk
Decision Guide
Which is
right for you?
Choose Human Chorionic Gonadotropin (HCG) if...
- Fertility preservation during TRT
- Maintaining testicular size and function
- Natural testosterone stimulation
- Post-cycle therapy recovery
Choose Leuprolide if...
- Managing advanced or metastatic prostate cancer
- Controlling severe endometriosis pain
- Treating symptomatic uterine fibroids
- Delaying early puberty in children